PLANNING COMMITTEE MEMBERS
Mark Westwood PhD; Karen Ordovas MD
Reviewed by: Anupama Rao MD (November 8, 2019)
The planners/faculty for this activity have no relevant relationships to disclose.
FACULTY
Matthias Friedrich MD; Peter Kellman PhD; Daniel Messroghli MD; Martin Ugander MD, PhD; Erica Dall'Armellina PhD; Orlando Simonetti PhD
Dr. Simonetti has grant/research support from Siemens and Cook MEDInstitute. He has received consulting fees from Vannevar Group. He is a stock shareholder (self-managed) in EXCMR, Inc.
- Understand biomarkers impact on treatment and the characteristics of a good one
- Define the current techniques of mapping and the underlying technologies
- Understand the clinical need for native T1 Mapping
- Learn advances in technologies effecting mapping techniques
- Identify potential limitations and advantages when T1 Mapping